CMA
65
-6
FSLR
58
3
CLX
51
-2
SYK
30
2
LEN
30
-3
STX
67
-6
LMT
55
-4
MAC
67
2
EOG
36
-9
CAT
66
2
CNX
46
-3
LH
40
-3
EL
61
3
NVDA
49
3
AAL
53
2
EFX
52
2
JBHT
63
3
APH
49
4
FLR
40
2
OXY
38
-2
CMA
65
-6
FSLR
58
3
CLX
51
-2
SYK
30
2
LEN
30
-3
STX
67
-6
LMT
55
-4
MAC
67
2
EOG
36
-9
CAT
66
2
CNX
46
-3
LH
40
-3
EL
61
3
NVDA
49
3
AAL
53
2
EFX
52
2
JBHT
63
3
APH
49
4
FLR
40
2
OXY
38
-2
Financhill
Back

Hikma Pharmaceuticals Plc Stock Predictions

Share Price Moved. Momentum Hasn't Slowed.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
33

HKMPY
Hikma Pharmaceuticals Plc

Last Price:
$40.42
Seasonality Move:
2.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Hikma Pharmaceuticals Plc Stock Forecast

  • Over the next 52 weeks, Hikma Pharmaceuticals Plc has on average historically risen by 8.8% based on the past 15 years of stock performance.
  • Hikma Pharmaceuticals Plc has risen higher in 9 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Hikma Pharmaceuticals Plc Stock Undervalued?
    The current Hikma Pharmaceuticals Plc [HKMPY] share price is $40.86. The Score for HKMPY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • HKMPY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Hikma Pharmaceuticals Plc Stock Go Up Next Year?

  • Over the next 52 weeks, Hikma Pharmaceuticals Plc has on average historically risen by 8.8% based on the past 15 years of stock performance.

Hikma Pharmaceuticals Plc Stock Rating

Sell
33
Hikma Pharmaceuticals Plc (HKMPY) is a Sell

Is Hikma Pharmaceuticals Plc overpriced?

  • Hikma Pharmaceuticals Plc has risen higher in 9 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Hikma Pharmaceuticals Plc Stock Price History

Is HKMPY stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HKMPY is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
United Kingdom
Industry:
Sector:
Type:
stock
Website:
hikma.com

52-Week Data

52-Week High:
59.26
52-Week Low:
40.14

Prediction Charts

Market Cap:
4.5B
Price in USD:
40.86
Volume:
240
Beta:
0.46

Technical Analysis

SMA50:
44.16
SMA100:
46.00
SMA200:
49.89
52-Wk Change:
-16.21%

Stock Predictions

  • Is Hikma Pharmaceuticals Plc stock public?
    Yes, Hikma Pharmaceuticals Plc is a publicly traded company.
  • What is the Hikma Pharmaceuticals Plc stock quote today?
    The Hikma Pharmaceuticals Plc stock price is 40.86 USD today.
  • How to buy Hikma Pharmaceuticals Plc stock online?
    You can buy Hikma Pharmaceuticals Plc shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 41.82 41.45 41.98 41.43
Dec-3 41.87 42.09 42.09 41.87
Dec-4 42.09 42.09 42.09 42.09
Dec-5 42.36 42.73 42.73 42.35
Dec-8 42.22 41.96 42.22 41.96
Dec-9 41.82 41.00 41.90 41.00
Dec-10 41.40 41.22 41.40 40.89
Dec-11 42.04 41.48 42.04 41.48
Dec-12 41.05 40.14 41.05 40.14
Dec-15 40.99 40.72 40.99 40.72
Dec-16 40.57 40.57 40.57 40.57
Dec-17 40.99 40.39 40.99 40.39
Dec-18 40.86 40.86 40.86 40.86
Dec-19 40.42 40.42 40.42 40.42

Hikma Pharmaceuticals Plc Earnings

Data Unavailable

Hikma Pharmaceuticals Plc Forecast Revenue Growth

Data Unavailable

* Hikma Pharmaceuticals Plc stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.